324 related articles for article (PubMed ID: 34235638)
21. Applications of genome editing tools in precision medicine research.
Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
23. Personalised genome editing - The future for corneal dystrophies.
Moore CBT; Christie KA; Marshall J; Nesbit MA
Prog Retin Eye Res; 2018 Jul; 65():147-165. PubMed ID: 29378321
[TBL] [Abstract][Full Text] [Related]
24. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing.
Iqbal Z; Rehman K; Xia J; Shabbir M; Zaman M; Liang Y; Duan L
Biomater Sci; 2023 May; 11(11):3762-3783. PubMed ID: 37102700
[TBL] [Abstract][Full Text] [Related]
25. An Update on the Application of CRISPR Technology in Clinical Practice.
Morshedzadeh F; Ghanei M; Lotfi M; Ghasemi M; Ahmadi M; Najari-Hanjani P; Sharif S; Mozaffari-Jovin S; Peymani M; Abbaszadegan MR
Mol Biotechnol; 2024 Feb; 66(2):179-197. PubMed ID: 37269466
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.
Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK
AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365
[TBL] [Abstract][Full Text] [Related]
27. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.
Kong H; Ju E; Yi K; Xu W; Lao YH; Cheng D; Zhang Q; Tao Y; Li M; Ding J
Adv Sci (Weinh); 2021 Dec; 8(24):e2102051. PubMed ID: 34665528
[TBL] [Abstract][Full Text] [Related]
28. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
29. CRISPR technologies for the treatment of Duchenne muscular dystrophy.
Choi E; Koo T
Mol Ther; 2021 Nov; 29(11):3179-3191. PubMed ID: 33823301
[TBL] [Abstract][Full Text] [Related]
30. Futuristic approach to cancer treatment.
Malik D; Mahendiratta S; Kaur H; Medhi B
Gene; 2021 Dec; 805():145906. PubMed ID: 34411650
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.
Vachey G; Déglon N
Methods Mol Biol; 2018; 1780():463-481. PubMed ID: 29856031
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9 Genome Editing Approaches for Psychiatric Research.
Gutiérrez-Rodríguez A; Cruz-Fuentes CS; Genis-Mendoza AD; Nicolini H
Braz J Psychiatry; 2023 May; 45(2):137-145. PubMed ID: 36753615
[TBL] [Abstract][Full Text] [Related]
33. Base Editing: Efficient Installation of Point Mutations with Minimal Byproducts.
Newby GA
Stem Cells Dev; 2019 Jun; 28(11):712-713. PubMed ID: 31107171
[No Abstract] [Full Text] [Related]
34. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
35. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
Hohmann S
Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
[No Abstract] [Full Text] [Related]
36. CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
Happi Mbakam C; Lamothe G; Tremblay G; Tremblay JP
Neurotherapeutics; 2022 Apr; 19(3):931-941. PubMed ID: 35165856
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
Jensen TI; Axelgaard E; Bak RO
Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders.
Ugalde L; Fañanas S; Torres R; Quintana-Bustamante O; Río P
Cytotherapy; 2023 Mar; 25(3):277-285. PubMed ID: 36610813
[TBL] [Abstract][Full Text] [Related]
39. Making gene editing a therapeutic reality.
Conboy I; Murthy N; Etienne J; Robinson Z
F1000Res; 2018; 7():. PubMed ID: 30613384
[TBL] [Abstract][Full Text] [Related]
40. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview.
Araldi RP; Khalil C; Grignet PH; Teixeira MR; de Melo TC; Módolo DG; Fernandes LGV; Ruiz J; de Souza EB
Gene; 2020 Jun; 745():144636. PubMed ID: 32244056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
